The Role of daf-19 in Non-Ciliated Neurons: How is Neural Development Regulated by Different daf-19 isoforms? by Ek Vazquez, Zabdiel
Lawrence University
Lux
Lawrence University Honors Projects
Spring 6-1-2016
The Role of daf-19 in Non-Ciliated Neurons: How
is Neural Development Regulated by Different
daf-19 isoforms?
Zabdiel Ek Vazquez
Lawrence University, ekvazquz@lawrence.edu
Follow this and additional works at: https://lux.lawrence.edu/luhp
Part of the Developmental Biology Commons, Developmental Neuroscience Commons,
Genetics Commons, Integrative Biology Commons, Molecular and Cellular Neuroscience
Commons, Molecular Biology Commons, Molecular Genetics Commons, Other Cell and
Developmental Biology Commons, Other Genetics and Genomics Commons, and the Other
Neuroscience and Neurobiology Commons
© Copyright is owned by the author of this document.
This Honors Project is brought to you for free and open access by Lux. It has been accepted for inclusion in Lawrence University Honors Projects by an
authorized administrator of Lux. For more information, please contact colette.brautigam@lawrence.edu.
Recommended Citation
Ek Vazquez, Zabdiel, "The Role of daf-19 in Non-Ciliated Neurons: How is Neural Development Regulated by Different daf-19
isoforms?" (2016). Lawrence University Honors Projects. 92.
https://lux.lawrence.edu/luhp/92
The Role of daf-19 in Non-Ciliated Neurons 
How is Neural Development Regulated by Different daf-19 Isoforms? 
Lawrence University 
Zabdiel Ek-Vazquez 
Research Mentor: Elizabeth Ann De Stasio 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Thesis Submitted in Candidacy for Honors at Graduation from Lawrence University 
May 2016
ABSTRACT 
A degenerative disease-like phenotype, specifically reduction in synaptic protein levels 
in adult worms, is correlated with loss-of-function of the only RFX transcription factor gene, 
daf-19, in C. elegans. This gene encodes four known transcription factor isoforms, two of which 
are correlated with particular functions. The DAF-19C isoform activates genes responsible for 
cilia development, while DAF-19M is needed for cilia specification in males. A comparison of the 
transcriptome of daf-19 null and isogenic wild type adult worms suggests both positive and 
negative regulation of gene expression is correlated with the presence of DAF-19 proteins. We 
have assessed DAF-19 regulation of gene expression using transcriptional fusion constructs of 
putative target genes in daf-19 wild type and mutant worms. We have found that at least three 
genes are repressed by the DAF-19 transcription factor in particular nerve cells. In one case, 
differential gene expression is seen in sensory neurons while differential expression of two 
other genes is limited to interneurons. Interestingly, none of these genes have been shown to 
contain an X-box, the cis-acting sequence used to activate genes involved in cilia formation. 
These data suggest that DAF-19 has an additional role beyond that of sensory neuron 
development and specification. Because the daf-19 gene produces at least four related 
proteins, further experimentation is required to determine which DAF-19 isoform(s) are 
responsible for repression of gene expression. We are currently using new alleles of daf-19 to 
determine whether the largest DAF-19 proteins, DAF-19A/B have a role in repressing target 
gene expression. 
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INTRODUCTION: 
The development of the nervous system depends on setting aside cells to eventually 
become the nervous system. Presumptive nerve cells must then migrate to adult positions, 
differentiate, grow axons and dendrites, form functional synapses, and survive (Hobert, 2005; 
Schmitz, 2007; Middlelkoop, 2014). All cells, including neurons, have the same genetic 
information in their nucleus in the form of tightly wound DNA. However, not all cells express 
the same genes. It is the unique expression of different gene combinations that distinguishes a 
neuronal cell from other cell types. For example, nerve cells contain the same 19,735 genes 
that are found in all C. elegans cells but typically only express a subset of those genes at any 
given time (Hillier et al., 2005).  Both expression and repression of genes are responsible for 
establishing a wide array of cell types with varying shapes, functions, and locations. Some 
neurons express greater or fewer genes than other neurons, depending on whether the neuron 
is specialized for sensation, movement, or it becomes an interneuron connecting sensory and 
motor neurons to one another. 
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The Nervous System of C elegans 
 
 
 
 
 
 
 
 
 
In C. elegans, the cells of the nervous system are organized into clusters called ganglia. 
The majority of these clusters can be found in the heads and tails of worms. The majority of C. 
elegans neurons are located in the head around the pharynx. In addition, there are two small 
posterior lateral ganglia on the sides, as well as some scattered neurons along the lateral body. 
The processes from most neurons travel in either the ventral or dorsal nerve cord and project 
to the nerve ring (NR) in the head. The nerve ring constitutes the major neuropil in animals. 
 
Figure 1. A partial depiction of the C. elegans neuronal network. Long tracts 
represent axons and dendrites. Spheres represent neuronal cell bodies. Anterior of 
the worm is facing the left while the posterior of the worm faces the right. Credit: 
The OpenWorm Project, image generated by neuroConstruct 
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C. elegans is a powerful model organism that can be used as a developmental and 
genetic tool for neuronal studies. The transparency of this worm allows scientists to visualize its 
cells in vivo throughout its entire lifespan. Consequently, this worm is the only organism for 
which the entire cell lineage is known (Ward et al., 1975; Sulston, 1983). That is, every cell in its 
body can be traced to the beginning of the worm’s development and its path of differentiation 
is known (Huang & Sternberg, 2005). Similarly, it is the only animal for which each cell has been 
fully mapped, such that the developmental birth and death of every single cell, including 
neurons, is known (see Figure 1; Varshney, 2011). What is even more fascinating is that these 
pioneering studies also revealed how all of these neurons are connected to one another—the 
so-called connectome—which is allowing researchers to better link the particular function of 
single neurons to the entire neural circuit (Chalfie et al., 1985; Hart, 2006). 
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 Neurons have two functional ends (Figure 2). This basic functional morphology of 
neurons in C. elegans parallels the functional organization of neurons in the human nervous 
system. This basic functional feature involves a simple “input-output” mechanism. In the input 
portion of this mechanism, sensory projections (dendrites) at one end of the neuronal cell body 
receive information from other neurons or directly from the environment via antennae-like 
devices named “cilia” that sense their chemical and physical environments. Information is then 
transmitted to the cell body. After being processed in the cell body, an outgoing neural signal 
will be sent to the other end of the cell—through the neuron’s axon, the outgoing projection of 
a neuron.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The overall structure of a neuron. Neural signals initiate at the 
dendrites or soma, then travel through the axon to the terminal buttons, and 
synapse onto other neurons, tissues, or glands. Image taken from: 
http://neuropsychologysket-ches.com/Neurons.html 
Axonal Signal Output 
Dendritic Sensory Input 
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There are four main types of neuronal cell identities in C. elegans that share the 
aforementioned “input-output” mechanism: ciliated sensory neurons, non-ciliated sensory 
neurons, interneurons (or polymodal neurons) and motor neurons (Hobert, 2005; Varshney, 
2011). Interneurons connect ciliated and non-ciliated neurons in different combinations, while 
motor neurons connect the nervous system to muscle cells (Varshney, 2011). Cilia are 
antennae-like sensory receptors that project from particular neuronal cells inside C. elegans to 
either the internal body of the worm or the outside environment, see Figure 4 (Ward, 1975; 
Blacque et al., 2005; Inglis et al., 2008). Cilia have different structures, and thus different 
functions (Figure 4). This allows ciliated neurons to directly collect and transmit a wide range of 
internal and environmental signals to other cells within the worm, including neurons and 
muscles. Non-ciliated sensory neurons, interneurons, and motor neurons play a large role in the 
conduction and coordination of internal and environmental signals to produce a variety of net 
behavioral outputs. 
Both ciliated and non-ciliated neurons release neurotransmitters to communicate with 
one another. Therefore, it is important to understand the mechanisms that regulate the 
specification of neuronal cells into both ciliated and non-ciliated neurons. This developmental 
mechanism is especially important to understand, because neurodegenerative disease like 
Alzheimer’s, Huntington’s, and Parkinson’s are associated with the loss of synaptic proteins in 
neuronal cells (Arnaud et al., 2006). 
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Figure 3.  Neurons in C. elegans have two functional ends: the sensory input, or dendritic 
end, and the signal output, or axonal projection. In a C. elegans, a neuron’s cell body can 
have two projections if it is a bipolar neuron (A), or one projection if it is a monopolar neuron 
(B). Any other branching (C & D) just extends from these two primary cell projections. Taken 
from WormAtlas. 
A B C 
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Regulation of Genes in the C. elegans Nervous System 
Gene expression is activated by proteins called transcription factors, which physically 
bind to DNA and initiate the transcription of nearby genes into mRNA. Following translation of 
mRNAs, the resulting proteins can function as enzymes, ion channels, receptors, structures, or 
other transcription factors. Gene expression also can be repressed by proteins whose 
expression is activated by transcription factors. In other words, the activation of one or multiple 
genes by a transcription factor may lead to the repression of other genes. Therefore, 
transcription factors can be indirectly involved in the repression of genes. The observation of 
both repression and activation of genetic expression is called differential gene expression. 
Differential gene expression is driven in some cells of the C. elegans nervous system by 
the daf-19 transcription factor gene, which encodes the RFX transcription factor protein, DAF-
19. RFX transcription factor genes, like the daf-19 gene, are important to study because they 
control the expression of genes involved in the maintenance and survival of a healthy nervous 
system (Bonnafe, 2004; Senti & Swoboda, 2008; El Zein et al., 2009; Segun-Estevez et al., 2009; 
Piasceki et al., 2010). A full deletion of the daf-19 gene impedes the expression of genes that 
are dependent on DAF-19 for transcription. A complete deletion of the daf-19 gene correlates 
with a reduction in synaptic protein levels in adult worms and neurodegenerative-disease-like 
symptoms as well as the abolition of all ciliary structures on sensory neurons (Swoboda, 2000; 
Chen et al., 2006; Inglis et al., 2008; Senti & Swoboda, 2008). Consequently, the absence of the 
daf-19 gene can lead to diseases of the nervous system, like Alzheimer’s, Huntington’s, and 
Parkinson’s disease. This neurodegenerative mechanism is important to understand because 
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orthologs of the daf-19 transcription factor gene exist in the human genome (Aftab et al., 
2008). Versions of the daf-19 gene, called RFX transcription factor genes, have also been found 
in Drosophila, Saccharomyces cerevisiae, Schizosaccharomyces pombe, and mouse (Emery et 
al., 1996; Vandaele et al., 2001; Dubruille et al., 2002). Therefore, RFX transcription factors 
orthologous to DAF-19, are thought to be conserved across the entire eukaryotic kingdom 
(Emery et al., 1996). This makes C. elegans a powerful model organism to understand the role 
of RFX transcription factors in neurodegeneration (Driscoll et al., 2003; Link, 2005; Murakami, 
2007).  
DAF-19 proteins (green ribbons in Figure 5) bind to DNA and control the expression of 
other genes. More specifically, once bound to a specific DNA sequence, a DAF-19 protein will 
recruit or activate the assembly of transcription machinery at nearby transcription start sites. 
The daf-19 gene encodes four different versions, or 
isoforms, of related DAF-19 transcription factor 
proteins. The availability of different versions of the 
DAF-19 protein allows for differential gene 
regulation by different isoforms of the same gene. 
These daf-19 isoforms differentially regulate genes 
found in the nervous system. When the daf-19 
gene is expressed, exon splicing sometimes creates 
longer or shorter versions of the DAF-19 
transcription factor protein. The short versions of 
 
Figure 5. DAF-19 RFX transcription 
factor (green) binding to DNA. Taken 
from RFX1 image on Wikipedia.  
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DAF-19 (DAF-19C and DAF-19M) have been found to bind to specific, evolutionarily conserved 
DNA sequences called x-boxes in the promoter regions of target genes (Zhang et al., 1993; 
Efimenko, 2005). Not only do the short versions of DAF-19 activate genes differentially 
themselves, they also work in conjunction with different x-boxes to regulate the location and 
intensity of gene expression (Chu et al., 2012; Henriksson et al., 2013). Therefore, the 
combination of both different DAF-19 transcription factor proteins and different DAF-19 DNA 
target sequences (x-boxes) contribute to the differential regulation of gene expression. 
Only two of the DAF-19 protein isoforms have identified functions (Senti and Swoboda, 
2008; Wang et al., 2010). The functions of the smaller proteins, DAF-19C and DAF-19M, are well 
known. The DAF-19C isoform is expressed exclusively in ciliated sensory neurons, where it 
activates genes responsible for cilia development (Swoboda, 2000; Dubruille et al., 2002; Chen 
et al., 2006; Senti & Swoboda, 2008). This process, called ciliogenesis, is responsible for the 
generation of cilia, which are antennae-like protrusions from the dendrite that permit neuronal 
cells to sense particular chemicals, for example, in their environment. The DAF-19M isoforms 
control neuronal gene expression in particular ciliated neurons in the male tail and can be said 
to specify the function of these neurons (Wang et al., 2010). Thus, DAF-19C specifies a neuron 
as a ciliated sensory neuron while DAF-19M specifies the identity of particular ciliated sensory 
neurons in males only.   
The daf-19 gene produces two closely related longer proteins called DAF-19A/B whose 
functions are unknown (Swoboda, 2000; Senti & Swoboda, 2008). In collaboration with 
researchers at the Karolinska institute, we hypothesize that the DAF-19A/B protein isoforms are 
Ek-Vazquez, 11 
 
responsible for controlling neuronal gene expression in non-ciliated neurons. Further, Senti & 
Swoboda (2008) showed that worms lacking all DAF-19 proteins showed marked reductions in 
synaptic proteins as adults (but corresponding RNA levels were normal) whereas daf-19 null 
worms expressing DAF-19A protein from an added cDNA clone had normal synaptic protein 
levels at the same ages. Thus, DAF-19A is said to rescue this synaptic phenotype. We therefore 
further hypothesize that DAF-19A is responsible for controlling the expression of genes that 
maintain synaptic protein levels, either directly or indirectly.  
 
The DAF-19 Project 
 
 
 
 
 
 
 
 
 
 
Figure 6. daf-19 isoforms. daf-19 encodes four different proteins. DAF-19C 
directs cilia formation. DAF-19M confers some cilia identity in males. DAF-19A/B 
have unknown functions. Adapted from Wang et al. (2010). 
 
Of6-53bp 
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Lab Strain Genotype Description 
LU 628 daf-19(tm5562) six times back-
crossed 
865 bp deletion as follows: 583 bp from 
intron 1 + 189 bp exon 2 (entire exon) + 
93 bases of intron 2. Only exon 2 in 
both DAF-19A and B is deleted. 
LU 3063 daf-19(m86)II Changes an arginine codon to a UGA 
stop codon (called an opal mutation) in 
exon 7.  Lacks all DAF-19 proteins. 
LU 3738 daf-19(WT); daf-12(sa204)X; him-
5(e1490)V 
Contains all DAF-19 proteins 
LU 652 daf-19(of6); him-5(e1490) 
sEX:pC52D10.6 
53 bp deletion of the 3' end of exon 4, 
including the splice site at the 3' end. 
Mutation affects only DAF-19B isoform 
OF 5 daf-19(of5)II A net deletion of 12 bases (16 bp 
deletion and a 4 bp insertion that 
includes an ATG in the +1 reading 
frame). 
LU 664 daf-19(m86); daf-12(sa204); him-
5 + daf-19C from pGG14 + elt-
2::gfp 
The daf-19(m86) allele was 
supplemented with a transgene 
containing a cDNA copy expressing 
DAF-19C. 
LU 668 daf-19(m86); daf-12(sa204);him-
5 + daf-19A unc-122::gfp and 
F57B10.9::gfp 
The daf-19(m86) allele was 
supplemented with a transgene 
containing a cDNA copy expressing 
DAF-19A. 
 
The long isoforms of daf-19, DAF-19A/B, are implicated in the regulation of genes found 
in non-ciliated neurons based on the observation that DAF-19A/B isoforms are expressed in all 
non-ciliated neurons and only in non-ciliated neurons (Senti & Swoboda, 2008). When DNA 
solely expressing DAF-19A is added to worms missing all other DAF-19 proteins, most 
behavioral and cellular phenotypes were rescued (Senti & Swoboda, 2008). Therefore, DAF-
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19A/B might regulate genes involved in the maintenance and survival of a healthy nervous 
system.  
DAF-19A/B transcription factor proteins may bind to DNA sequence motifs similar to x-
box motifs bound by DAF-19C and M (see Figure 7; Senti & Swoboda, 2008). Alternatively, DAF-
19A/B may use other partner proteins, via its dimerization domain, to bind to novel DNA 
sequence motifs. Once DAF-19A/B target genes have been characterized, we will be able to 
compare promoter regions of these genes to identify common DNA sequence motifs. 
Differential regulation of genes in specific types of neurons by different daf-19 isoforms 
suggests an important role for daf-19 isoforms in neural development and behavior. In fact, the 
mutations to DAF-19A/B transcription factor proteins will provide evidence as to whether or 
not these longer daf-19 isoforms control gene expression necessary for protection against 
neurodegeneration. Overall, this information highlights the importance of the RFX transcription 
factor in both behavior and the development of the nervous system. 
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Figure 7. DAF-19 transcription factor proteins 
activate genes in ciliated and non-ciliated 
neurons. The DAF-19C protein regulates genes 
that have a common genetic sequence (called 
‘x-boxes’) and that drive ciliogensis. On the 
other hand, it is not well known what types of 
genes the DAF-19A/B proteins control in order 
to indirectly regulate synaptic maintenance. 
Taken from Senti and Swoboda, 2008. 
 
My research aims to (i) identify 
neural genes controlled by the DAF-19 RFX 
transcription factor, (ii) elucidate whether 
daf-19-target genes are controlled by the 
DAF-19A/B versions.  Finally, (iii) I want to 
characterize the expression of genes that 
are DAF-19A/B-regulated, and (iv) identify 
the cells in which these DAF-19A/B-
regulated genes are differentially 
expressed. 
 
 
 
Approach: Biological Tools Used to Explore DAF-19 Gene Regulation: 
Transcriptome Analysis 
The transcriptome is a collection of mRNA expressed in an organism or tissue at the 
time that the cells were lysed and RNA collected. De Stasio and Phirke (unpublished) used a 
microarray containing probes for 18,000 genes to characterize the transcriptome of adult and 
larval worms (respectively). A comparison of the transcriptome of daf-19 null and isogenic wild 
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type adult worms suggests both positive and negative regulation of gene expression is 
correlated with the presence of DAF-19 proteins.  
A transcriptome of daf-19 null animals is a record of all the genes that are activated or 
suppressed when all DAF-19 protein versions are gone. For example, if a gene is activated only 
when daf-19 is gone, this suggests that in a wild type animal, daf-19 normally represses activity 
of that gene either directly or indirectly. On the other hand, if a gene is repressed when daf-19 
is gone, but is activated in the presence of daf-19, one can conclude that daf-19 normally 
activates this gene in a wild type worm.  The transcriptome of wild type worms of matched age 
serves as a control, or list of genes that are normally transcribed when all DAF-19 protein 
versions are present and functional in C. elegans. 
The transcriptome analysis using microarrays identified 170 potential DAF-19A/B 
transcription factor protein targets. Thirty-four of these genes were chosen for further analysis 
using a transcriptional fusion of the upstream putative control region of our target genes to 
DNA encoding GFP. These transcriptional fusions were expressed in isogenic strains to assess 
gene expression patterns in the presence and absence of DAF-19 proteins. Isogenic worms have 
the same genetic background with the exception of one mutant gene. In this study, daf-19 wild 
type (daf-19(WT)) and worms lacking all known DAF-19 proteins, daf-19(m86) worms, were 
used to study the regulation of neural genes when DAF-19A/B is mutated or completely non-
functional. In addition, the De Stasio lab was able to procure DAF-19A/B-specific mutants and 
create additional isogenic strains by mating these mutants with worms expressing 
transcriptional fusions for our target genes (F57B10.9 and F52D2.2). This means that we can 
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assess how daf-19 target neuronal genes are regulated by the DAF-19A/B protein-isoform. So, 
not only am I able to distinguish between the effects of different DAF-19 protein versions, I am 
also able to discriminate between different parts of a specific DAF-19 protein. 
Transcriptional Fusions: Using Fluorescent Proteins to Tag and Visualize a Gene of Interest 
How do we know which genes are and which genes are not controlled by certain DAF-19 
protein versions? Many biological tools can be used to signal the presence and/or absence of a 
particular gene. In my research, I used transcriptional fusions to genetically tag a gene of 
interest with a gene that encodes a fluorescent protein (Figure 8). Once a transcriptional fusion 
is made, the fluorescent protein will be expressed whenever and wherever the gene of interest 
is expressed. Consequently, the fluorescent protein will mimic the expression of any gene we 
want by physically tagging that gene. These transcriptional fusion constructs are called 
“transgenes” when they are expressed in an animal or plant. 
There are different colors of fluorescent proteins: green fluorescent protein (GFP), red 
fluorescent protein (RFP), yellow fluorescent protein (YFP), etc. When one of these fluorescent 
proteins is illuminated with a particular wavelength of light, that wavelength of light will excite 
electrons within the fluorescent protein that will absorb a portion of the light and emit a 
wavelength of light that corresponds to the designated color of the protein. As a result of this 
color-specific emission and the transparency of C. elegans, we are able to spatially and 
temporally localize the expression of any gene.  
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This construct is known as a transcriptional fusion because although GFP is produced via 
the transcriptional control elements of our different target genes, our target genes are not 
produced into proteins by the plasmid, though these genes are still being expressed from 
normal, chromosomal copies. GFP is, therefore, produced in the cells that express the 
transcription factors that bind to the control elements of our target genes, but the GFP protein 
does not localize to the specific cellular locations where our target gene functions. Therefore, 
Figure 8. Segment of a plasmid that contains the transcriptional fusion 
construct. An example of how a fluorescent protein (GFP or RFP) is genetically 
tagged onto a gene of interest (i.e daf-19). A 5’ fragment of the target gene 
(F57B10.9 and F52D2.2, and daf-19) is fused to a GFP gene to make a 
transcriptional fusion. In this construct, the transcription of GFP is driven by the 
target gene promoter. Only GFP protein is made from this plasmid construct. 
Image adapted from: http://www.nature.com/nrg/journal/v4/n6/fig_tab- 
/nrg1087_F5.html 
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we are not able to draw inferences about the specific locations within a cell where our target 
genes (F57B10.9 and F52D2.2) might function by visually localizing the GFP protein. 
In order to obtain a temporal representation of reporter gene expression, transgenic 
worms of all ages were imaged, thus yielding a developmental representation of the expression 
patterns of any reporter gene. In order to identify the ages of individual worms, I compared the 
images I produced via confocal microscopy to WormAtlas schematics of the developmental 
stages of hermaphroditic worms (Appendix 1A). Similarly, to determine the precise cells in 
which the reporter gene is differentially expressed, I compared the images I produced via 
confocal microscopy to WormAtlas schematics of neuronal maps (Altun and Hall, 2012). It is 
important to note that the absence of fluorescence does not mean that neurons are not 
present. Rather, the absence of fluorescence merely means that the reporter gene is not 
expressed in the non-fluorescent neurons. 
The ability to determine precise expression patterns of each fluorescent, transcriptional 
reporter gene has allowed us to characterize not only the location and stage of development at 
which genes are transcribed, but also the number of cells in which a reporter gene is 
transcribed. Therefore, I have also used transgenes to quantify the difference in the expression 
patterns of daf-19 WT worms and daf-19 null mutant worms. Quantifying the expression of 
reporter genes is a measure of the penetrance of a gene.  
Quantifying the expression of reporter genes is necessary because the expression 
patterns of transgenes expressed from extra-chromosomal arrays varies from animal to animal 
due to genetic mosaicism. The reporter gene is microinjected into the hermaphrodite gonad 
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along with a co-injection marker and carrier plasmid, known as an extra-chromosomal array. 
This array is not inherited reliably along with the genomic DNA during cell division. 
Consequently, an unstable number of transgene arrays will be present in the progeny of 
transgenic worms. In fact, there will also be slight variations in cell-to-cell expression between 
individuals of a single strain, thus resulting in mosaicism and an inconsistent pattern of 
transgene expression. It is therefore necessary to visualize various individual worms in order to 
deduce a representation of transgene expression patterns. 
Biological Replicates: “Second Lines” of C. elegans with the Same Transcriptional Fusions 
To test whether daf-19 isoforms consistently regulate the same genes, in the same 
neurons, at the same stages of development, I have used biological replicates of C. elegans with 
the same transcriptional fusions. These biological replicates are called “second lines” because 
they are C. elegans strains with transcriptional fusions injected into a different worm’s gonad. 
This approach has allowed me to deduce whether I see reproducible differences amongst the 
various daf-19 isogenic mutants. If I had not used second lines of C. elegans strains, the 
differences in fluorescent gene expression could be attributed to other phenomena.  
Obtaining Different daf-19 mutants: 
 C. elegans mutants were obtained from our collaborators in Stockholm (m86, of5, of6) 
and from the Mitani lab in Japan (tm5562). The latter mutant strain was back-crossed in our lab 
by Savannah Vogel and Kristen Bischell. Back-crossing mutants reduces any other mutations 
that the worm strain might have. Back-crossing involves mating the tm5562 mutant 6 
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generations with the wild type strain, OE3738. This process insures that we are only seeing the 
effects of an exon 2 deletion to the DAF-19A and B isoforms. 
MATERIALS AND METHODS 
Maintaining and Constructing C. elegans Strains 
 C. elegans strains were maintained on 5mm agar plates containing a centered, 
standardized quantity of the OP50 E. coli strain, which C. elegans fed on ad libitum. These 
plates were kept at 20o C.   
C. elegans strains were made with varying daf-19 genetic backgrounds. Consequently, 
worms that contained a transgene only had genetic variability in regards to the integrity of the 
daf-19 gene. Therefore, in a single strain of C. elegans, identical transgene arrays were 
transferred to worms with different daf-19 alleles by mating. Consequently, this approach 
allowed us to visualize differential transcription of the fluorescent protein in varying daf-19 
genetic backgrounds in vivo.  
Dye-Fill Assays:  
DiI is commonly used as an anterograde dye. That is, DiI is first absorbed by the cilia on 
the dendritic ends of neurons (Figure 4), and it then travels to the axonal projection via the 
neuronal body. The ability to absorb DiI requires cilia, therefore, only animals in which DAF-19C 
is expressed to drive ciliogenesis—the generation of cilia—are able to absorb the DiI. This 
anterograde dye is, therefore, useful to distinguish C. elegans with cilia and therefore 
expressing DAF-19C from worms lacking this isoform and therefore also lacking cilia. 
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 Worms were washed off agar plates with 1 mL of M9 buffer and placed into a 1 mL 
Eppendorf. This mix was centrifuged and most of the M9 buffer removed along with bacteria, 
leaving a loose pallet of worms. A sufficient volume of M9 was added to the tube to bring the 
total volume to 0.5 mL. 3 uL of DiI (2mg/mL) was added to the tube mixture. Worms were then 
incubated in the DiI-M9 mixture for one hour at 25oC. Worms were then washed in M9 buffer 
once and placed on streaked agar plates containing a standard dose of the OP50 E. coli strain. 
Worms were then allowed to eat and defecate for at least 12 hours to remove dye from the 
intestinal tract prior to visualization by fluorescent microscopy. This 12 hour recovery period 
also helped reduce the intensity of the fluorescent signal from DiI in neurons, thus providing 
clearer confocal images. 
Confocal Microscopy Preparation and Image Acquisition 
 Healthy transgenic worms from non-starved NGM plates were collected into an 
Eppendorf tube by washing their plates with 1mL of M9 buffer. 1.5mL of 2% agarose in M9 
buffer was then heated and mixed with 15uL of sodium azide, to temporarily paralyze the 
worms. A thin, circular gel pad was formed by pipetting 5uL of the agarose mixture onto the 
center of a glass slide. The circular pad was used to immobilize transgenic worms for confocal 
imaging. 3 to 5uL of M9 buffer containing transgenic worms was added onto the gel and a 
coverslip was placed on top to prevent it from drying and to facilitate imaging with the use of a 
thin piece of glass. 
 Transgenic worms were imaged with a Leica confocal microscope. Argon and HeNe 543 
lasers at 10% power were used along with detectors (HyD) that were set to capture the 
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wavelengths of light emitted as GFP and dsRED or DiI (for dye-filled worms). Display colors were 
set as green and red, respectively. 
RESULTS:  
The data collected in the current study supports the hypothesis that F57B10.9 and 
F52D2.2 are differentially regulated in specific neurons by DAF-19A/B isoforms. To accomplish 
this goal, I examined daf-19 isogenic strains that carried either F57B10.9 or F52D2.2 chimeric 
transgenes. That is, I produced worm strains that had mutations in the daf-19 gene and then 
mated each of these strains, separately, with a single transgenic strain carrying the GFP 
reporter gene for either F57B10.9 or F52D2.2. Specifically, I produced transgenic strains with 
the of5, tm5562, and of6 variations of daf-19 to determine if expression of F57B10.9 and 
F52D2.2 transgenes is DAF-19A/B dependent. Finally, I compared the images I produced using 
confocal microscopy to neuronal schematics in WormAtlas, and thus identified the specific 
neurons in which the chimeric transgenes were differentially expressed. By identifying the 
neurons expressing the transgene and understanding what the typical functions of these 
neurons are, we may be able to gain novel insight into the function of the F57B10.9 and 
F52D2.2. Analysis of transcriptional GFP fusion expression patterns by confocal microscopy 
revealed reproducible expression of GFP in a subset of neurons in hermaphrodites. A 
description of each gene and a detailed analysis of the expression pattern of each 
transcriptional fusion is provided below.  
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The F57B10.9 Gene  
F57B10.9 is orthologous to the human gene SPG20, or Spg-20 (Shaye and Greenwald, 
2011; Truong et al., 2015). In fact, a Clustal Omega protein sequence alignment of these genes 
found them to have 65% similarity. Mutations in SPG20 which result in the complete loss of 
expression of the protein spartin lead to Troyer syndrome (Patel et al., 2002), which is 
characterized by spasticity of the leg muscles, progressive muscle weakness, paraplegia, muscle 
wasting in the hands and feet (distal amyotrophy), small stature, developmental delay, learning 
disorders, speech difficulties (dysarthria), and mood swings, exaggerated reflexes in the lower 
limbs (hyperreflexia), skeletal abnormalities, and a bending outward of the knees (valgus) 
(Bakowska et al., 2008). The name SPARTIN thus derives from these symptoms: Spastic 
Paraplegia Autosomal Recessive Troyer syndrome. 
Spartin also shares sequence similarity with spastin (Ciccarelli et al., 2003). The 
sequence shared by spartin and spastin is similar to that of proteins involved in the morphology 
and membrane trafficking of endosomes—compartments of the endocytotic membrane 
transport pathway that originate in the Golgi membrane (Phillips et al., 2002). Most notably, 
spastin is thought to be involved in a particular mechanism of endosomal transportation that 
involves microtubules (Phillips et al., 2002). When overexpressed, spastin binds to microtubules 
and this action results in the redistribution the microtubule array. Spartin shares the N-terminal 
region of spastin that is capable of binding to microtubules (Ciccarelli et al., 2003; Renvoise et 
al., 2010). Therefore, spartin is predicted to also be involved with microtubule interaction and 
trafficking. 
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In the nervous system, modest SPG20 expression has been found in fetal and adult 
human brains, including the amygdala, cortex, and thalamus (Auer-Grumbach et al., 1999; 
Manzini et al., 2010). Lower levels of expression have been found in the hippocampus and 
cerebellum. In the mouse brain, SPG20 has similar expression levels to the human brain, except 
that higher levels of expression were found in the hippocampus and spinal cord (Manzini et al., 
2010). Additionally, SPG20 has been  found to be developmentally regulated, with maximum 
expression at midgestation and embryonic day 10 with a precipitous decline thereafter. Even 
though SPG20 is present in nervous tissue in fetal stages, only low levels of it are expressed in 
the adult mouse brain. Interestingly, SPG20 is present in only low levels of expression in 
neurons and glia of the hippocampus and forebrain, and throughout the cerebellum, brainstem, 
and spinal cord (Manzini et al., 2010). Due to the large differences in the fluctuation of SPG20 
expression levels, it is thought that SPG20 plays a role in morphogenesis and differentiation at 
several sites, including the initial frontonasal mass/forebrain, craniofacial structures, aortic 
arch/heart primordium, and limb buds during morphogenesis in mice (Manzini et al., 2010). For 
these reasons, F57B10.9 was chosen from the list of putative daf-19 regulated genes as possibly 
having a role in neuronal function. 
Characterizing F57B10.9 Gene Expression 
Confocal microscopy was used to image F57B10.9::GFP transgene expression in worms 
with different daf-19 genetic backgrounds. F57B10.9::GFP expression was assessed in male and 
hermaphrodite worms of all larval stages of development including adulthood. Specifically, 
F57B10.9::GFP expression was assessed and recorded in the IL2 neuronal pair, the pharyngeal 
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region near the nerve ring; ventral, dorsal, and lateral nerve cords; and in the intestine, body 
wall muscle, hypodermis, epidermis, vulva, and tail of each worm (Appendix 1B). Consequently, 
I was able to quantify the expression of the reporter transgene in both sexes and deduce a 
representation of F57B10.9::GFP expression patterns throughout development. 
Previous research by McKay and colleagues (2003) has shown that F57B10.9::GFP 
expression occurs in the nerve ring; ventral, dorsal, and lateral nerve cords; and in amphid, 
mechanosensory, pharyngeal, and tail neurons of adult worms. Korzynski (2012), Zhang (2013), 
and Hurlburt (2014) found similar expression patterns in worms containing all DAF-19 proteins 
(daf-19(WT)) and in worms lacking all DAF-19 proteins (daf-19(m86)). Overall, they found that 
F57B10.9::GFP was consistently expressed in nerve cords, ventral nerve cord motor neurons, 
body neurons, tail neurons, and in approximately 20 neurons in the pharyngeal region. In 
addition to its significant presence and role in the nervous system, a 1.58 fold up-regulation of 
F5B10.9 mRNA in adult daf-19 mutant worms, makes F57B10.9 a promising DAF-19A/B target 
gene. I used previous records of F57B10.9::GFP tissue and neuronal expression to inform my 
own investigations. Furthermore, I searched for and recorded the expression of the 
F57B10.9::GFP transgene in the tissues where the transgene was previously observed to be 
expressed by McKay et al. (2003), Korzynski (2012), Zhang (2013), and Hurlburt (2014).  
F57B10.9::GFP expression in daf-19(WT) worms, which contain all DAF-19 isoforms 
In worms expressing all DAF-19 proteins, daf-19(WT) worms, F57B10.9 transgene 
expression was found to be consistently activated in the ciliated IL2 neurons (indicated by a 
dotted square in Figure 9A) and a small cluster of non-ciliated neurons found in the isthmus 
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region (Appendix 1B) of the pharynx of hermaphrodite worms (indicated by a dotted circle in 
Figure 9A; and Hurlburt, 2014). One hundred percent of worms, 59 total, with a daf-19(WT) 
genetic background displayed F57B10.9::GFP expression in the ciliated IL2 sensory neurons. In 
addition, one hundred percent of worms displayed expression of the reporter gene in at least 
20 neurons in the pharyngeal region, posterior to the IL2 neurons. Further F57B10.9::GFP 
expression was also observed in the nerve cords (92%), body neurons (93%), 3-5 tail neurons 
(95%), and body wall muscle (63%). These results were consistent across worms of all stages of 
larval development and adulthood. In summary, one hundred percent of daf-19(WT) worms, 
which contain all DAF-19 proteins, display F57B10.9::GFP expression in the ciliated IL2 neuronal 
pair.  
F57B10.9::GFP expression in daf-19(m86) worms, which lack all DAF-19 isoforms 
Recall that worms that have an m86 mutation in the daf-19 gene lack all DAF-19 
proteins and, therefore, cannot produce cilia to absorb DiI. Consequently, these mutants were 
identified by their inability to dye-fill and their green transgene fluorescence.  
In contrast to daf-19(WT) worms, F57B10.9::GFP transgene expression in worms (N = 
31) lacking all DAF-19 proteins (daf-19(m86) mutants) was never found in the ciliated IL2 
neuronal pair (indicated by the dotted square in Figure 9B). One hundred percent of all daf-
19(m86) mutants showed transgene expression in at least 20 neurons in the pharyngeal region, 
posterior to the ciliated IL2 neurons (indicated by the dotted circle in Figure 9B). However, 
compared to daf-19(WT) worms, F57B10.9::GFP transgene expression in daf-19(m86) mutants 
was found in a larger number of neuronal bodies posterior to the anterior bulb of the pharynx. 
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Additional transgene expression was also found in the ventral nerve cords (97%), body neurons 
(84%), 3-5 tail neurons (97%), and body wall muscle (10%). These results were consistent across 
worms of all stages of larval development and adulthood. Conclusively, worms lacking all DAF-
19 proteins do not express the F57B10.9::GFP transgene in IL2 neurons, but do express the 
transgene in a larger number of posterior neuronal bodies than daf-19(WT) worms.  
The identity of IL2 neurons was previously determined by Alex Hurlburt (2014); he also 
found no age-related difference in transgene expression. The identity of IL2 neurons was 
confirmed through a modified calcium acetate dye-fill assay (Appendix 1D; and Tong and 
Burglin, 2010; Hurlburt, 2014) that specifically stains IL2 neurons (indicated by white arrows in 
Figure 20). Since IL1 neurons are also ciliated and they structurally resemble IL2 neurons, it was 
especially crucial to eliminate the IL1 neurons as a possible location for differential 
F57B10.9::GFP expression. The only noticeable morphological difference between IL1 neurons 
and IL2 neurons is the shape of their axonal projections. The axonal projections of IL2 neurons 
have the shape of hooks and they should not interlink (Figure 9). In contrast, the axonal 
projections of the IL1 neurons are barely separated from one another and they are much more 
dispersed (Figure 9). Notice how the morphology of these two different types of neurons is 
indistinguishable (Figure 9).  
Thus far, this investigation has added to the findings of Korzynski (2012), Zhang (2013), 
and Hurlburt (2014) in that daf-19(WT) worms and worms lacking all DAF-19 proteins (daf-
19(m86)) showed differences in F57B10.9::GFP expression pattern. Most notably, daf-19(WT) 
worms express F57B10.9::GFP in IL2 neurons while daf-19(m86) mutants did not. In addition, 
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daf-19(m86) mutants showed transgene expression in a larger number of neuronal bodies in 
the posterior region of the pharynx. Consequently, worms with a daf-19(WT) and daf-19(m86) 
genetic background have been pivotal in understanding the effects of DAF-19 proteins on 
F57B10.9::GFP expression. However, these genetic backgrounds are not sufficient to 
understand the isoform-specific roles of different DAF-19 isoforms on F57B10.9::GFP 
expression. Thus, the rest of my investigations involved characterizing the expression patterns 
of the F57B10.9::GFP transgene in different DAF-19A/B genetic backgrounds. 
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Figure 9. Axonal projections of IL1 neurons and IL2 (Fig 10) neurons are indistinguishable.  
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F57B10.9::GFP expression in daf-19(of5) worms, which lack DAF-19A and B isoforms 
F57B10.9::GFP transgene expression in worms lacking the DAF-19A/B proteins, that is 
worms with a daf-19(of5) mutant background, revealed GFP expression in the ciliated IL2 
neurons (indicated by dotted square in Figure 12D) of every worm analyzed (N = 41). 
 
Left-side image of IL2 neurons (6 total) taken from WormAtlas. 
 
Calcium acetate staining to identify IL2 neurons (white arrow).  
Green: F57B10.9::GFP. Red: DiI. Image taken from Alex Hulrburt  
(2014). White scale bars are 20 µm. 
 
daf-19(WT) worms display F57B10.9::GFP expression in IL2 neurons 
(white arrow). Green: F57B10.9::GFP. Red: DiI. Image taken from  
Alex Hurlburt (2014). White scale bars are 20 µm. 
 
Figure 10. Using calcium acetate staining to identify IL2 neurons. 
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Interestingly, 20% of the worms analyzed showed F57B10.9::GFP expression in only two of the 
three IL2 neuronal pairs. The IL2 neuronal pair that did not exhibit F57B10.9::GFP expression 
varied tremendously; thus, F57B10.9::GFP expression was not consistently present or absent in 
a specific neuronal subset of IL2 pairs. On the other hand, F57B10.9::GFP expression was 
observed in all three IL2 neuronal pairs in 70% of the worms analyzed. 
In addition, F57B10.9::GFP expression was always found in a cluster of neuronal bodies 
posterior to the IL2 neuronal pairs (indicated by dotted circle in Figure 12D). Even more 
specifically, neuronal bodies were always found both anterior and posterior to the nerve ring. 
The number of posterior neuronal bodies expressing F57B10.9::GFP is much larger in daf-
19(of5) animals than that seen in daf-19(WT) animals. In fact, the larger number of posterior 
neurons expressing the transgene resembles the transgene expression levels present in daf-
19(m86) mutants. 
Additional expression of the transgene was observed in the nerve cords (100%), body 
wall muscle (93%), and tail neurons (100%). Transgene expression was not, however, observed 
in the intestine (0%) or vulva’s (0%) of worms. The expression of the transgene in all of these 
different tissues and neurons did not differ across different larval stages of development or 
adulthood. Transgene expression patterns were developmentally consistent from the first larval 
stage (L1) to old adult worms (OA). 
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F57B10.9::GFP expression in daf-19(tm5562) worms, which lack exon two of DAF-19A/B 
Worms that have a tm5562 mutation in the daf-19 gene lack exon two of the DAF-19 A 
and B isoforms and, therefore, can still produce cilia to absorb DiI. Consequently, these mutants 
were identified by their green transgene fluorescence and their ability to dye-fill. 
Similar to daf-19(WT) worms, F57B10.9::GFP transgene expression in daf-19(tm5562) 
worms was always found in ciliated IL2 neurons (indicated by dotted a square in Figure 12C). 
However, F57B10.9::GFP transgene expression in daf-19(tm5562) mutants was consistently 
found in a larger number of neuronal bodies posterior to the anterior bulb of the pharynx 
(indicated by dotted circle in Figure 12C).Transgene expression in daf-19(tm5562) mutants 
occurred in a larger number of posterior neurons than transgene expression in daf-19(WT) 
worms (indicated by the dotted circle in Figure 11A). Transgene expression in the posterior 
neurons of daf-19 (tm5562) mutants is, therefore, most like that of daf-19(m86) mutants. 
However, transgene expression in the ciliated IL2 neurons of daf-19(tm5562) mutants is most 
similar to transgene expression in the IL2 neurons of mutants which lack all DAF-19 proteins, 
daf-19(m86) mutants (indicated by dotted square in Figure 11B). Additional transgene 
expression was also found in the ventral nerve cords (95%), body neurons (100%), 3-5 tail 
neurons (92%), and body wall muscle (92%). However, transgene expression was not observed 
in the intestine (0%) or vulva’s of daf-19(tm5562) worms (0%). 
While these transgene expression patterns were found to be consistent across all stages 
of larval development and adulthood, it is important to note that the high consistency of 
F57B10.9::GFP expression in body wall muscle was unique to daf-19(tm5562) mutants (92%) 
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and daf-19(WT) worms (63%). In contrast, only ten percent of daf-19(m86) worms displayed 
F57B10.9::GFP expression in the body wall muscle. Therefore, while F57B10.9::GFP expression 
is downregulated in response to the absence of all DAF-19 proteins (daf-19(m86) mutants), its 
expression is aberrantly upregulated when worms lack only the amino acids encoded by exon 
two of the DAF-19A/B isoforms—the daf-19(tm5562) mutation. 
F57B10.9::GFP expression in daf-19(of6) worms, a mutation to DAF-19B  
The of6 mutation only alters the DAF-19B isoform. By altering the DAF-19B isoform of a 
F57B10.9::GFP transgenic strain, I was able to visualize and understand how these alterations 
affect the F57B10.9::GFP expression. The following results are, therefore, a record of how 
F57B10.9::GFP expression varies in a genetic background where the DAF-19B isoform has been 
altered. It is important to recall that transgene expression was carefully documented in the 
specific tissues and cells that include the IL2 neurons; the dorsal, ventral, and lateral nerve 
cords; ventral nerve cord motor neurons, intestine, body wall muscle, hypodermis, epidermis, 
vulva, and tail of each worm (N = 24). 
F57B10.9::GFP expression in a daf-19(of6) mutant background was always found in IL2 
neurons (indicated by a dotted square in Figure 12E) and in the posterior cluster of neurons 
(indicated by a dotted circle in Figure 12E). Specifically, transgene expression always occurred in 
cells both anterior and posterior to the nerve ring. However, F57B10.9::GFP transgene 
expression did not occur in as many cell bodies as in the daf-19(m86) genotype. In fact, it seems 
to be expressed in few neuronal bodies—an expression pattern very similar to that of 
F57B10.9::GFP expression in a daf-19(WT) background (indicated by dotted circle in Fig. 11A).  
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Additional F57B10.9::GFP expression was found in the ventral nerve cords (100%), body 
neurons (100%), body wall muscle (83%), hypodermis (96%), and tail neurons (100%). While the 
transgene was expressed in multiple tissues, the expression of the transgene remained 
consistent throughout all larval stages and adulthood. In summary, worms with an altered DAF-
19B isoform express the F57B10.9::GFP transgene in IL2 neurons, but they only express the 
transgene in a small number of neuronal bodies posterior to the IL2 neurons. 
F57B10.9::GFP expression in worms that overexpress the DAF-19C isoform 
 In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a 
transgene containing a cDNA copy expressing DAF-19C, the F57B10.9::GFP transgene was 
always expressed in all three IL2 neuronal pairs (indicated by a dotted square in Figure 13F). 
That is, when only DAF-19C is overexpressed in worms that previously lacked transgene 
expression in IL2 neurons, F57B10.9::GFP expression is “rescued” in all three IL2 neurons with 
one hundred percent penetrance. That is, F57B10.9::GFP expression goes back to “normal” 
when DAF-19C is overexpressed in worms that previously lacked all DAF-19 proteins. This 
transgene expression pattern in the IL2 neurons, therefore, resembles that seen in worms 
containing all DAF-19 proteins (daf-19(WT) worms). Overall, transgene expression in IL2 
neurons is similar in worms that exclusively overexpress DAF-19C, daf-19(WT) worms, daf-
19(of6) mutants, daf-19(of5) mutants, and daf-19(tm5562) mutants. 
In worms that overexpress only the DAF-19C isoform, F57B10.9::GFP expression always 
occurred in a small cluster of neurons posterior to the IL2 neurons (indicated by a dotted circle 
in Figure 13F). More specifically, the transgene expression that occurred in neurons posterior to 
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the IL2 neurons occurred in both anterior and posterior locations relative to the nerve ring. Low 
levels of transgene expression in the posterior neurons were also seen in daf-19(WT) worms. 
Additional F57B10.9::GFP expression was found in the ventral nerve cords (83%) and tail 
neurons (100%). The expression patterns that I observed in this DAF-19C rescue were 
consistent in at all stages of development and adulthood. I can thus conclude that DAF-19C is 
not responsible for WT expression of F57B10.9 in neurons posterior of the nerve ring. 
F57B10.9::GFP expression in worms that overexpress the DAF-19A isoform 
In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a 
transgene containing a cDNA copy expressing DAF-19A, the F57B10.9::GFP transgene was never 
expressed in IL2 neurons (indicated by dotted square in Figure 13G). That is, transgene 
expression in the IL2 neurons of worms that previously lacked all DAF-19 proteins, was not 
rescued with the overexpression of DAF-19A. Therefore, DAF-19A overexpression was not 
sufficient to activate transgene expression in the ciliated IL2 neurons and produce a genotype 
and phenotype that resembles transgene expression in daf-19(WT) worms.  
Worms overexpressing DAF-19A always show F57B10.9::GFP expression in the same 3 
cell bodies (indicated by dotted circles in Figure 13G), which reside in the general pharyngeal 
region. Two of these three cell bodies were identified as neurons. To identify which specific 
neurons these were, I compared the confocal images that I produced to WormAtlas schematics 
of neurons in the pharyngeal region (Appendix 1B). The morphology of their axonal projections, 
cell bodies, and dendritic branching resembles that of the I5 and either the OLQ or OLL neuron. 
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Fig 14. Summary of F57B10.9::GFP Expression in Different daf-19 Backgrounds 
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F52D2.2 (rgs-8.1) Gene Background 
The F52D2.2 gene was chosen for analysis based on its orthology to the human gene, 
RGSL1 (regulator of G-protein signaling like 1) and members of the RGS (regulators of G-protein 
signaling) family including RGS13. F52D2.2 gene has five exons and it encodes a protein that 
regulates other proteins. More specifically, F52D2.2, or rgs-8.1, is a regulator of G-protein 
signaling. G proteins—which belong to a group of enzymes called GTPases—are a family of 
proteins inside cells that transmit stimuli outside of a cell to the cell’s interior. The activity of G 
proteins is regulated by factors that control their ability to bind to and hydrolyze GTP and GDP. 
When G proteins are bound to GTP, they are activated. However, when they are bound to GDP, 
they are deactivated. 
Evidence of differential F52D2.2::GFP expression in worms of different developmental 
stages with different daf-19 genetic backgrounds made the F52D2.2 gene an especially 
interesting DAF-19 target gene to explore. The transcriptome microarray of three-fold stage 
embryos (indicated by a red circle in Appendix 1C) revealed that, when compared to 
F52D2.2::GFP expression levels in daf-19 wild type embryos, daf-19(m86) embryos 
demonstrated a 0.66 fold decrease in the levels of transgene expression (Phirke, 2011). 
Meanwhile, the expression levels of the transgene was less severely impacted in daf-19 mutant 
worms at the L1 larval stage of development. In contrast, De Stasio’s analysis of adult worms 
revealed that in daf-19(m86) mutants, transgene expression levels were reduced (0.36 fold) 
when compared to the expression levels of the transgene in daf-19 wild type worms (De Stasio, 
unpublished). 
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Due to its reduced levels of expression across different stages of development in the 
presence and absence of daf-19, F52D2.2 was investigated as a possible DAF-19A/B target 
gene. Bonnie Arbuckle (unpublished) from the De Stasio lab previously characterized the 
expression of the F52D2.2::GFP transgene in both a daf-19(WT) and daf-19(m86) genetic 
background.  
Characterizing F52D2.2 Gene Expression 
A transcriptional fusion consisting of 2677 base pairs of DNA upstream of the ATG start 
codon of F52D2.2 was fused to the coding region of GFP, thus yielding the F52D2.2::GFP 
transgene that spatially and temporally mimics the expression of the F52D2.2 gene. Confocal 
microscopy was used to image and analyze F52D2.2::GFP expression in male and 
hermaphrodite worms with different daf-19 genetic backgrounds at all stages of larval 
development and adulthood. Consequently, I was able to quantify the expression of the 
reporter gene in both sexes and deduce a representation of F52D2.2::GFP expression patterns 
throughout development. Finally, I used previous records of F52D2.2::GFP cell and tissue 
expression to inform my own investigations. Furthermore, I searched for and recorded the 
expression of the F52D2.2::GFP transgene in the tissues where the transgene was previously 
observed to be expressed by Bonnie Arbuckle (unpublished). 
Bonnie Arbuckle (unpublished), from the De Stasio lab, noted F52D2.2::GFP expression 
in worms with a daf-19+ and a daf-19- genetic background. While Arbuckle recorded the 
expression of the transgene in various cells and tissues, she eventually determined that the only 
transgene expression differences amongst daf-19+ and a daf-19- worms existed in the ventral in 
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the I2 neuronal pair (Figure 15). I have confirmed the identities of these neurons by comparing 
Arbuckle’s confocal images to neuronal schematics on WormAtlas (Figure 15).  
In daf-19(WT) animals (N = 37), Arbuckle noticed that 25% of worms analyzed expressed 
the transgene in the ventral nerve cord (indicated by white arrows in Figure 16A). However, 
none of these worms displayed transgene expression in I2 neurons (indicated by dotted circle in 
Figure 16A). Arbuckle’s findings revealed additional transgene expression in tail neurons 
(100%). However, transgene expression was never observed in the body wall muscle, 
hypodermis, or epidermis of daf-19(WT) worms. The expression patterns observed both by me 
and by Bonnie Arbuckle are representative of all stages of larval development and adulthood. 
Patterns of F52D2.2::GFP expression are, therefore, consistent throughout the development of 
C. elegans. 
F52D2.2::GFP expression in daf-19(m86) worms, which lack all DAF-19 isoforms 
Next, the F52D2.2::GFP extrachromosomal array was transferred to daf-19(m86) worms 
(N = 36), which lack all DAF-19 isoforms. F52D2.2::GFP expression was imaged and analyzed in 
the I2 neurons and in the VNC of worms with a daf-19(m86) genetic background. As a result, 
Arbuckle (unpublished) noticed that the transgene was expressed in the VNC (indicated by 
white arrows in Figure 16B) with 60% penetrance. Thus, transgene expression in the VNC was 
preserved in the absence of all DAF-19 proteins. It is important to note that the penetrance of 
the transgene’s expression in the VNCs of worms analyzed was higher in worms with a daf-
19(m86) background, 60%, than worms with a daf-19(WT) background, 25%. 
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Arbuckle also noticed that, in 70% of worms, the transgene was expressed in an 
additional pair of neurons—the I2 neurons (indicated by the dotted circle in Figure 16B). 
Therefore, in daf-19(m86) mutants, the transgene is consistently expressed in an extra pair of 
neuronal bodies when compared to transgene expression in daf-19(WT) worms. My own 
investigations confirmed Arbuckle’s findings and revealed additional transgene expression in 
tail neurons (100%). However, I did not find transgene expression in the body wall muscle, 
hypodermis, or epidermis of daf-19(WT) worms. The expression of the transgene was variable, 
but overall, it was consistent across all stages of larval development and adulthood. 
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Figure 15. F52D2.2::GFP expression in I2 neurons is only seen in worms with a 
daf-19(m86) and a daf-19(of5) genetic background. Notice the similarity in the 
unique anterior process (green arrows) of I2 neurons. I2 neurons were identified by 
comparing the images I produced via confocal microscopy to I2 neuronal 
schematics on WormAtlas. White bars: 20 µm. 
F52D2.2::GFP expression in a daf-19(m86) 
background. The transgene is expressed in I2 neurons 
(dotted circle) and in the VNC (white arrows).  
 
WormAtlas illustration of I2 neurons(top). GFP 
expression in left and right IL2 neurons (bottom). 
 
F52D2.2::GFP expression in a daf-19(of5) background. 
The transgene is expressed in I2 neurons (dotted 
circle) and in the VNC (white arrows).  
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F52D2.2::GFP expression in daf-19(of5) worms, which lack the DAF-19A and B isoforms 
While transgene expression was characterized in the presence and absence of all DAF-
19 isoforms, analysis of daf-19(WT) and daf-19(m86) worms is not sufficient to understand the 
isoform-specific roles of DAF-19A/B. The chimeric transgene was, therefore, transferred to daf-
19(of5) mutants (N = 30), which possess a mutation that renders the DAF-19A and B isoforms 
non-functional. Consequently, the following results characterize the expression patterns of 
F52D2.2::GFP in worms lacking solely the DAF-19A/B isoforms. 
Seventy percent of daf-19(of5) worms analyzed displayed F52D2.2::GFP expression in 
the I2 neuronal pair (indicated by a dotted circle in Figure 17D).  Transgene expression was also 
found in the VNCs of all worms analyzed (indicated by white arrow in Figure 17D). This 
transgene expression pattern is similar to that seen in daf-19(m86) mutants. Additional 
transgene expression was found in other body neurons (13%), cells near the vulva (< 1%), 
hypodermis (< 1%), and tail neurons (100%). While transgene expression in daf-19(of5) mutants 
was variable, especially in body neurons, it is important to note that these results are a 
collective representation of mosaic, extra-chromosomal F52D2.2::GFP expression across all 
developmental stages including adulthood. The expression patterns provided are, therefore, 
developmentally consistent. 
F52D2.2::GFP expression in daf-19(tm5562) worms, which lack exon two of DAF-19A/B 
The previous investigation of F52D2.2::GFP expression in mutants lacking solely DAF-
19A/B was further narrowed by exploring the role of a specific amino acid sequence in the DAF-
19A/B isoforms. The daf-19(tm5562) mutant provides the opportunity for such an analysis. The 
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tm5562 mutation in daf-19 is a deletion to solely the second exon of both DAF-19A and B 
isoforms. By transferring the F52D2.2::GFP transgene to a daf-19(tm5562) genetic background, 
I was able to visualize and record the expression patterns of the transgene in worms that lack 
the amino acid sequence encoded by exon 2 of the DAF-19A and B isoforms. 
Confocal imaging of several daf-19(tm5562) worms (N = 36) revealed the complete 
absence of F52D2.2::GFP expression in I2 neurons (indicated by a dotted circle in Figure 17C). 
Therefore, a complete loss of the amino acids encoded by exon 2 of the DAF-19A/B isoforms 
does not result in transgene expression in the I2 neurons. It is important to note, however, that 
F52D2.2::GFP expression still occurs in the ventral nerve cord (25%, white arrow in Figure17C). 
The expression patterns collected via confocal microscopy for daf-19(tm5562) mutants 
expressing F52D2.2::GFP are consistent throughout all developmental stages. 
F52D2.2::GFP expression in daf-19(of6) worms, a mutation to DAF-19B 
 Worms (N = 36) with a mutation to DAF-19B never showed F52D2.2::GFP expression in 
the I2 neurons (indicated by dotted circle in Figure 17E). However, transgene expression in daf-
19(of6) mutants was always observed in the VNC of these animals. The overall transgene 
expression pattern in daf-19(of6) mutants resembles that seen in wild type animals, which 
contain all DAF-19 proteins. Since transgene expression was not upregulated in the absence of 
DAF-19B, it clear that the suppression of F52D2.2::GFP expression is not dependent on DAF-
19B.  
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F52D2.2::GFP expression in worms that overexpress the DAF-19C isoform 
In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a 
transgene containing a cDNA copy expressing DAF-19C, the F52D2.2::GFP transgene was never 
expressed in I2 neurons (indicated by dotted circle in Figure 18F) or in the ventral nerve cords 
of animals (indicated by white arrows in Figure 18F). That is, when only DAF-19C is 
overexpressed in worms that previously displayed transgene expression in I2 neurons, 
F52D2.2::GFP expression is completely lost in all dye-filling worms overexpressing DAF-19C. This 
complete loss of transgene expression in the I2 neurons and in the VNC is, therefore, a unique 
expression pattern that is exclusive to worms overexpressing DAF-19C.  
F52D2.2::GFP expression in worms that overexpress the DAF-19A isoform 
In a doubly transgenic strain in which the daf-19(m86) allele was supplemented with a 
transgene containing a cDNA copy expressing DAF-19A, the F52D2.2::GFP transgene was never 
expressed in I2 neurons (indicated by dotted circle in Figure 18G).  
That is, transgene expression in the I2 neurons of worms that previously lacked all DAF-
19 proteins, was not rescued with the overexpression of DAF-19A (indicated by dotted circle in 
Figure 18G). Therefore, DAF-19A overexpression was not sufficient to activate transgene 
expression in the ciliated IL2 neurons and produce a genotype and phenotype that resembles 
transgene expression in daf-19(WT) worms.  
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Worms overexpressing DAF-19A consistently show F52D2.2::GFP expression in 2-5 
previously unseen neuronal bodies (indicated by dotted circles in Figure 18G), which reside in 
the general pharyngeal region. I identified one of these cell bodies as the I5 neuron (blue arrow 
in Figure 19). To identify which specific neurons these were, I compared the confocal images 
that I produced to WormAtlas schematics of neurons in the pharyngeal region (Figure 19) 
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Confocal image shows I5 neuron. Green: F52D2.2::GFP expression in a worm overexpressing DAF-
19A is present in several cell bodies, including the I5 neuron (blue arrow).  
 
WormAtlas neuronal schematic of an I5 neuron. 
 
Figure 19. The morphology of the neuron (blue arrow) present in the confocal image (top) 
matches the unique morphology of the I5 neuronal schematic provided by Worm Atlas. 
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Fig. 20 Summary of F52D2.2::GFP Expression in Various daf-19 Backgrounds 
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DISCUSSION: 
F57B10.9 Expression is both activated and repressed by DAF-19 isoforms 
F57B10.9::GFP expression was consistently found in nervous tissue that includes nerve 
cords, neurons in the pharyngeal region of the head, tail neurons, and along the ventral body 
wall. Previous work by Alex Hurlburt (2014) revealed the identity of some neuronal bodies 
where transgene expression was DAF-19 dependent. Most notable, is the difference in the 
expression of the transgene in the IL2 neurons. Hurlburt (2014) not only identified these 
neuronal cell bodies as IL2 neurons via a modified calcium acetate dye-filling, but he also 
determined that only daf-19+ worms expressed the transgene in IL2 neurons.  
By knocking down and overexpressing different DAF-19 isoforms, I have determined 
that F57B10.9::GFP expression in IL2 neurons was only observed in worms in which the DAF-
19C isoform was expressed. Transgene expression in IL2 neurons was first observed in daf-19 
wild type worms, which contain all DAF-19 isoforms. However, when all DAF-19 proteins were 
knocked out, transgene expression in IL2 neurons was also lost. At this point in the investigation 
we knew that transgene expression in the IL2 neurons was activated by the daf-19 gene. 
However, this was not sufficient information to deduce which specific DAF-19 isoform was 
responsible for activating the expression of the transgene in IL2 neurons. Therefore, the of5, 
tm5562, of5, and of6 mutations in the daf-19 gene were instrumental to discovering the 
isoform-specific functions of the different DAF-19 isoforms. 
In the De Stasio lab, we specifically seek to understand how the DAF-19A and B isoforms 
regulate neuronal genes. To understand the functions of the DAF-19A and B isoforms, we 
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decided to knock down these two DAF-19 isoforms and observe transgene expression in this 
genetic background in vivo; thus, allowing the intact organism to demonstrate the effects of 
non-functional DAF-19A/B on F57B10.9::GFP expression. The consistent expression of the 
transgene in the IL2 neurons of worms lacking both DAF-19A and B isoforms suggests that 
transgene expression in IL2 neurons is DAF-19A/B independent. DAF-19A/B independence in IL2 
neurons is further supported by the consistent expression of the transgene in the IL2 neurons 
of daf-19(of5), daf-19(tm5562), and daf-19(of6) mutants—all of which contain mutations in 
only the DAF-19A and/or B isoforms. Moreover, the loss of transgene expression in the IL2 
neurons in daf-19(m86) mutants was rescued by solely overexpressing DAF-19C. This suggests 
that transgene expression in IL2 neurons is DAF-19C dependent. We can, therefore, infer that 
F57B10.9 expression is also DAF-19C dependent in IL2 neurons. In conclusion, DAF-19C is 
necessary for the expression of F57B10.9::GFP expression in IL2 neurons. My investigations, 
however, do not answer whether DAF-19C is sufficient for the transgene expression in IL2 
neurons. There are many other proteins that regulate the control elements of gene 
transcription and mRNA translation. 
Compared to daf-19(WT) worms, animals with mutations specific to the DAF-19A and B 
isoforms consistently showed differential transgene expression in a cluster of neurons posterior 
to the IL2 neurons. When all DAF-19 proteins were completely abolished, transgene expression 
was consistently found in a larger number of neuronal bodies located posteriorly to the IL2 
neurons (Hurlburt, 2014). At this point in time, the data collected suggested that transgene 
expression in those posterior neuronal bodies was DAF-19 dependent. More specifically, since 
transgene expression was upregulated in the absence of all DAF-19 isoforms, it was evident that 
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F57B10.9::GFP expression was normally repressed by daf-19. However, since we are particularly 
interested in the isoform specific functions of the DAF-19A and B isoforms, I transferred the 
transgene into several daf-19a/b mutants.  
As hypothesized, F5210.9::GFP expression in the posterior neurons of daf-19(of5) 
mutants was indeed upregulated.  Therefore, completely non-functional DAF-19A and B 
isoforms are associated with the upregulation of F57B10.9::GFP in neurons posterior to the IL2 
neurons. Therefore, it is clear that transgene expression in the cluster of posterior neuronal 
bodies is normally suppressed by DAF-19A and B isoforms. That is, transgene expression in the 
aforementioned posterior neurons is dependent on DAF-19A/B for suppression. Interestingly, I 
have associated this transgene suppression with the specific amino acid sequences encoded by 
exon two of the DAF-19A and B isoforms. 
Transgene expression in daf-19(tm5562) mutants is upregulated, suggesting that, in wild 
type worms the amino acids encoded by exon two largely contribute to the suppression of 
transgene expression in the aforementioned posterior neuronal cell bodies. Since a similar 
transgene expression was seen in daf-19(of5) mutants, I decided to rescue the DAF-19A isoform 
by overexpressing it. The purpose of overexpressing DAF-19A is to determine whether 
suppression of the transgene in the posterior neuronal bodies would be re-established to 
resemble wild type worms. As a result, transgene suppression in the posterior neurons was 
indeed re-established but to an even greater degree than in wild type worms. The 
overexpression of DAF-19A, therefore, over-suppresses transgene expression in neuronal 
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bodies posterior to the IL2 neurons. Another study may, instead, only rescue the amino acids 
encoded by exon 2 of the DAF-19 A and B isoforms.  
F52D2.2 Expression  
 F52D2.2::GFP expression was consistently found in the nervous system. With exception 
to the DAF-19C rescue, transgene expression was always found in the ventral nerve cord of 
worms. Wild type worms showed consistent transgene expression in the ventral nerve cord. 
However, in the absence of all DAF-19 proteins, transgene expression was seen in an additional 
pair of neurons, which I hypothesize to be the I2 neuronal pair. Since transgene expression is 
upregulated in the absence of DAF-19, this suggests that transgene suppression is dependent of 
DAF-19. My investigations with the other daf-19 genetic mutants revealed novel isoform-
specific regulatory roles for DAF-19 A and B. 
Only daf-19(m86) mutants and worms lacking both DAF-19A and B isoforms (daf-19(of5) 
mutants) displayed transgene expression in I2 neurons. Consequently, our hypothesis that DAF-
19A/B may regulate F52D2.2 expression is supported by the data collected from the daf-19(of5) 
mutant. However, further investigation led me to exclude transgene suppression in the I2 
neurons as solely DAF-19B dependent. When only DAF-19B is altered, as is the case in the daf-
19(of6) mutation, transgene expression is not seen in I2 neurons, but only seen in the ventral 
nerve cord. This suggests DAF-19B is either not involved in the suppression of F52D2.2 
expression, or it is not sufficient to repress the expression of the transgene in I2 neurons. 
Since the DAF-19B isoform is either not necessary or sufficient to suppress F52D2.2::GFP 
expression,  I continued to investigate the regulatory role of the DAF-19A/B isoforms on 
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F52D2.2 expression. The extrachromosomal array was transferred to a daf-19(tm5562) genetic 
background. Consequently, I was able to see the effects of losing exon 2 of the DAF-19 and B 
isoforms on F52D2.2 expression. In daf-19(tm5562) animals, transgene expression was 
consistently observed in the I2 neurons, thus suggesting that the amino acids encoded by exon 
2 of the DAF-19A and B isoforms is either necessary or sufficient (or both) to suppress the 
expression of the transgene in I2 neurons. 
Overexpressing DAF-19C resulted in the complete suppression of the transgene. 
Therefore, overexpression of DAF-19C is associated with downregulation of F52D2.2 
expression. It is important to note that wild type levels of DAF-19C expression are associated 
with transgene expression in the ventral nerve cord. However, once over expressed, DAF-19C 
represses the transgene in the same location. This study, therefore, has revealed that F52D2.2 
expression and repression is dose dependent on the levels of DAF-19C expression.   
By adding back DAF-19A to daf-19(m86) mutants, I hoped to determine whether the 
suppression of the transgene would be re-established. Interestingly, since DAF-19A was not 
expressed in wild type levels, but instead overexpressed, the transgene was consistently 
expressed in previously unseen neurons. One of these neurons was identified as the I5 neuron. 
The effects of DAF-19A overexpression on F52D2.2 expression has, therefore, proven to be 
unpredictable.  
CONCLUSIONS AND FUTURE RESEARCH 
 This study demonstrated that F57B10.9 expression is both activated and repressed by 
DAF-19 proteins. More specifically, I showed that in the IL2 neurons, DAF-19C is responsible for 
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the activation of F57B10.9::GFP expression. Simultaneously, I found that DAF-19 normally 
represses F57B10.9::GFP expression in neuronal bodies posterior to the nerve ring. More 
specifically, I was able to associate loss of transgene repression with the loss of the amino acids 
encoded by exon two of the DAF-19A and B isoforms. Next, I determined which DAF-19 
isoform, or combination thereof, is necessary and/or sufficient to maintain F57B10.9::GFP 
repression in the posterior neuronal bodies. I found that the of6 mutation to DAF-19B was not 
sufficient to inhibit transgene repression in the posterior cluster of neuronal bodies. In these 
daf-19(of6) mutants, DAF-19A was still normally expressed, which suggests that the integrity of 
DAF-19A expression is sufficient to maintain repression in the posterior cluster of neurons. 
Moreover, this suggests that the amino acids rendered non-functional in daf-19(of6) mutants 
are not necessary for transgene repression in the posterior cluster of neurons. This study also 
demonstrated that F52D2.2::GFP suppression is maintained by the amino acid sequences 
encoded by exon 2 of the DAF-19A and B isoforms. Further investigations could focus on 
identifying the specific neurons in which F57B10.9 and F52D2.2 are differentially expressed. 
Understanding the role of these specific neurons in the nervous system can guide future 
investigations into how the DAF-19 isoforms might affect the function of specific neural circuits. 
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Appendix 1A. C. elegans larval stages of development. 
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Appendix 1C. Life Cycle of C. elegans, taken from “Introduction to C. elegans Anatomy” 
(Altun et al., 2002). Circled (red) embryonic stage represents the 3-fold embryonic stage. 
 
